OSTX
OS Therapies Incorporated
1.70$
+0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.8% | 99.0% | 99.3% | 99.5% | 99.7% | 99.9% | 96.4% | 34.5% | 25.9% | 4.9% | 12.6% | 36.8% | |
| 2.5% | 4.9% | 9.6% | 7.1% | 94.0% | 99.9% | 69.9% | 27.2% | 21.0% | 3.9% | 12.6% | 2.1% | |
| 2.5% | 4.9% | 9.6% | 7.1% | 94.0% | 99.9% | 69.9% | 27.2% | 21.0% | 3.9% | 12.6% | 2.1% | |
| – | – | – | 4.6% | 3.9% | – | 0.6% | – | – | – | – | 31.3% | |
| – | – | – | – | – | – | 3.5% | 65.5% | 74.0% | 95.1% | 87.4% | 63.2% | |
| 3,545.6% | 3,109.2% | 2,531.7% | 2,116.4% | 135.8% | 85.3% | 198.5% | 34.5% | 47.4% | 189.1% | 248.3% | 208.6% | |
| 1,439.2% | 3,096.7% | 2,522.1% | 2,108.9% | 130.7% | 83.5% | 83.2% | 33.5% | 46.3% | 172.0% | 232.3% | 208.6% | |
| – | 1,830.7% | 1,483.9% | 1,244.1% | – | – | – | – | – | – | 18.4% | – | |
| 388.4% | 340.2% | 266.9% | 217.9% | 89.6% | 30.0% | 38.0% | 26.2% | 37.7% | 145.3% | 208.7% | 190.6% | |
| -3,445.6% | -3,009.2% | -2,431.7% | -2,016.4% | -35.8% | 14.7% | -98.5% | 65.5% | 52.6% | -89.1% | -148.3% | -109.6% | |
| -4,287.4% | -3,698.6% | -2,956.2% | -2,426.3% | -1,792.4% | -729.5% | -995.5% | -454.4% | -600.1% | -982.3% | -1,062.9% | -871.1% | |
| 3,534.4% | 2,512.2% | 1,911.4% | 1,534.6% | 804.0% | 2,234.7% | 500.0% | 243.6% | 356.9% | 427.7% | 529.8% | 443.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.